News
Google News: Ventana Signs Exclusive Licensing Agreement For The Commercialization Of A ...
[Laboratory Network] Germany to commercialize a novel immunohistochemistry (IHC) primary antibody developed by researchers Andreas von Deimling, MD, Hanswalter Zentgraf, PhD and David Capper, MD, to detect the V600E BRAF mutation protein. This new IHC diagnostic
Google News: Antikörper für die Krebsdiagnostik wird weltweit vermarktet
[gesundheit-adhoc.de] - Dr. Andreas von Deimling, Dr. David Capper und Prof. Dr. Hanswalter Zentgraf einen Antikörper, der diesen feinen Unterschied von nur einem einzigen Aminosäurebaustein erkennt, der die V600E-Mutation von normalem BRAF unterscheidet. Bei vielen
Verleihungen
www.aerzteblatt.de
Hans-Joachim-Dietzsch-Preis – verliehen von der Arbeitsgemeinschaft Pädiatrische Pneumologie und Allergologie, Dotation: Euro, gestiftet von MEDA-Pharma,...
Man, 80, devastated after being 'forced off' caravan park ...
www.cambridge-news.co.uk
· David Capper, says that his 80-year-old father was given four weeks to buy a new caravan or his would be removed. But David says his father simply could not afford £30,000 or more for a new ...
sorted by relevance / date